Insmed Inc (INSM): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$704.13M

Year ended 2023-12-31

2009-12-31 EBITDA (USD) 2023-12-31

Period ended	EBITDA	Change YoY	Source filing
2023-12-31	-$704.13M	n/m	2026-02-19, From 2023-01-01
2022-12-31	-$452.02M	n/m	2025-02-20, From 2022-01-01
2021-12-31	-$365.99M	n/m	2024-02-22, From 2021-01-01
2020-12-31	-$256.13M	n/m	2023-02-23, From 2020-01-01
2019-12-31	-$230.04M	n/m	2022-02-17, From 2019-01-01
2018-12-31	-$303.74M	n/m	2021-02-25, From 2018-01-01
2017-12-31	-$186.02M	n/m	2020-02-25, From 2017-01-01
2016-12-31	-$171.00M	n/c	2019-02-22, From 2016-01-01
2015-12-31	-$115.51M	n/m	2018-02-23, From 2015-01-01
2014-12-31	-$86.29M	n/m	2017-02-23, From 2014-01-01
2013-12-31	-$54.34M	n/m	2016-02-25, From 2013-01-01
2012-12-31	-$41.88M	n/m	2015-02-27, From 2012-01-01
2011-12-31	-$61.38M	n/m	2014-03-06, From 2011-01-01
2010-12-31	-$8.04M	n/m	2013-03-18, From 2010-01-01
2009-12-31	-$7.97M	n/a	2012-03-13, From 2009-01-01